Literature DB >> 6246804

Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection.

W E Beschorner, J Pino, J K Boitnott, P J Tutschka, G W Santos.   

Abstract

The morphologic changes in the livers of autopsy specimens from recipients of 62 allogeneic bone marrow transplants were reviewed and characterized in specimens from patients who had had apparent drug toxicity, graft-versus-host disease (GVHD), and disseminated cytomegalovirus (CMV) infection. Two conditioning protocols were associated with significant hepatic toxicity. Two of 3 recipients on whom autopsies were performed who had been prepared with high doses of carmustine, cyclophosphamide, and total body irradiation had undergone acute hepatic failure and submassive necrosis with periportal sparing. Seven of 9 patients prepared with busulfan (16 or 20 mg/kg) and cyclophosphamide had moderate to marked centrilobular sinusoidal fibrosis and associated hepatocellular atrophy and necrosis. Twenty of the patients had acute cutaneous GVHD with associated hepatic dysfunction, including 8 with disseminated CMV infection. Of the 12 patients without concomitant CMV infection, 5 had an early onset of GVHD and had predominantly periportal and focal midzonal hepatocellular necrosis, and 7 had acute GVHD with later onset with predominantly bile duct injury. Fifteen patients had evidence of disseminated CMV infection. Whereas CMV infection alone was associated with both hepatocellular and bile duct injury, detectable virus infection was not a requirement for hepatocellular or bile duct injury associated with GVHD.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246804      PMCID: PMC1903505     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Hepatic veno-occlusive syndrome in an American adult.

Authors:  R B SCOTT; J M BUDINGER; R A PRENDERGAST; I NYDICK
Journal:  Gastroenterology       Date:  1962-05       Impact factor: 22.682

2.  Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems.

Authors:  M Nesbit; W Krivit; R Heyn; H Sharp
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

Review 3.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

4.  Cytotoxic antibody for epithelial cells in human graft versus host disease.

Authors:  C B Merritt; D L Mann; G N Rogentine
Journal:  Nature       Date:  1971-08-27       Impact factor: 49.962

5.  Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients.

Authors:  R E Kanich; J E Craighead
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

6.  The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication.

Authors:  R E Slavin; G W Santos
Journal:  Clin Immunol Immunopathol       Date:  1973-07

Review 7.  The pathology of bone marrow transplantation.

Authors:  R E Slavin; J M Woodruff
Journal:  Pathol Annu       Date:  1974

8.  Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants.

Authors:  W E Beschorner; R Saral; G M Hutchins; P J Tutschka; G W Santos
Journal:  N Engl J Med       Date:  1978-11-09       Impact factor: 91.245

9.  Veno-occlusive disease of the liver after allogeneic bone marrow transplantation: possible association with graft-versus-host disease.

Authors:  P D Berk; H Popper; G R Krueger; J Decter; G Herzig; R G Graw
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

10.  Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.

Authors:  P F Griner; A Elbadawi; C H Packman
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

View more
  14 in total

1.  Bone marrow transplantation in the rat. III. Structure of the liver inflammatory lesion in acute graft-versus-host disease.

Authors:  D Leszczynski; R Renkonen; P Häyry
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

2.  Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.

Authors:  C Barbatis; P Kelly; J Greveson; A Heryet; J O McGee
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

Review 3.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

4.  Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy.

Authors:  C Torrecilla; J L Cortés; C Chamorro; J J Rubio; P Galdos; E Dominguez de Villota
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

5.  Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation.

Authors:  L B Grochow; R J Jones; R B Brundrett; H G Braine; T L Chen; R Saral; G W Santos; O M Colvin
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Liver disease after bone marrow transplantation.

Authors:  M J Farthing; M L Clark; J P Sloane; R L Powles; T J McElwain
Journal:  Gut       Date:  1982-06       Impact factor: 23.059

7.  Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features.

Authors:  H Einsele; H D Waller; P Weber; N Frickhofen; S Dette; H P Horny; A Roos; H Roos; H Hebart; H Schmidt
Journal:  Med Microbiol Immunol       Date:  1994-09       Impact factor: 3.402

8.  Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy.

Authors:  H P Bhagwatwar; S Phadungpojna; D S Chow; B S Andersson
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

9.  Serum Alanine Aminotransferase Elevations in Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort Study.

Authors:  Daniel M Green; Mingjuan Wang; Matthew J Krasin; DeoKumar Srivastava; Mary V Relling; Carrie R Howell; Kirsten K Ness; Sue C Kaste; William Greene; Dennis W Jay; Israel Fernandez-Pineda; Ching-Hon Pui; Sima Jeha; Michael W Bishop; Wayne L Furman; Leslie L Robison; Melissa M Hudson
Journal:  Hepatology       Date:  2018-12-25       Impact factor: 17.425

10.  Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease.

Authors:  Ashley E Stueck; Thomas D Schiano; M Isabel Fiel
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.